Treatment containers dispensed with Haversac Supply are captured in CDISC Drug Accountability (DA) standards for FDA Good Clinical Practice (GCP) compliance and for output to communication norms like the Study Data Tabulation Model (SDTM).  Haversac Supply is fully harmonized into the Haversac suite of applications including Haversac Randomization.  This means exact availability of time dependent Subject assigned treatments; even within complex crossover study designs with multiple epochs, treatments.